Amanote Research
Register
Sign In
EZH2 as a Therapeutic Target in Solid Tumors
Cancer Cell & Microenvironment
doi 10.14800/ccm.1024
Full Text
Open PDF
Abstract
Available in
full text
Date
October 27, 2015
Authors
Unknown
Publisher
Smart Science and Technology, LLC
Related search
EZH2 in Bladder Cancer, a Promising Therapeutic Target
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
NPM1 as a Potential Therapeutic Target for Atypical Teratoid/Rhabd Tumors
BMC Cancer
Cancer Research
Oncology
Genetics
Synthetic Genetic Array Screen Identifies PP2A as a Therapeutic Target in Mad2-Overexpressing Tumors
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Verification of EZH2 as a Druggable Target in Metastatic Uveal Melanoma
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Lysosomes as a Therapeutic Target
Nature Reviews Drug Discovery
Medicine
Drug Discovery
Pharmacology
CD38 as a Therapeutic Target
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Tax as a Therapeutic Target in ATL
Retrovirology
Virology
Infectious Diseases